FDA SEEKS INDUSTRY REPRESENTATIVE FOR NONPRESCRIPTION DRUGS PANEL

The FDA is requesting nominations for a nonvoting industry representative to serve on its Nonprescription Drugs Advisory Committee.

Organizations may nominate one or more individuals to serve on the committee or interested parties may self-nominate, according to an FDA public notice published in the Federal Register. Nominations must be submitted by Dec. 15.

The nonprescription drugs panel reviews and evaluates available data concerning the safety and effectiveness of OTC human drug products

.

For more information, go to http://www.fda.gov/OHRMS/DOCKETS/98fr/oc05267-n000001.pdf (http://www.fda.gov/OHRMS/DOCKETS/98fr/oc05267-n000001.pdf).